# Pharmacological Management of Delirium

> **NCT00842608** · NA · COMPLETED · sponsor: **Indiana University** · enrollment: 551 (actual)

## Conditions studied

- Delirium
- Cognitive Impairment

## Interventions

- **BEHAVIORAL:** Reduced exposure to anticholinergics
- **PROCEDURE:** Reduced exposure to benzodiazepines
- **DRUG:** Haloperidol
- **PROCEDURE:** Usual care

## Key facts

- **NCT ID:** NCT00842608
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 551 (ACTUAL)
- **Last updated:** 2018-08-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00842608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00842608, "Pharmacological Management of Delirium". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00842608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
